Pemetrexed Disodium (CAS 150399-23-8) is a cornerstone in the treatment of several significant cancers. Understanding its pharmacological properties is crucial for researchers, formulators, and anyone involved in the pharmaceutical value chain associated with this vital compound. This article provides a concise overview of Pemetrexed Disodium's mechanism of action, therapeutic applications, and its significance as a pharmaceutical intermediate.
Mechanism of Action: A Folate Antagonist
Pemetrexed Disodium belongs to a class of drugs known as antifolates. Its primary mechanism of action involves inhibiting key enzymes essential for purine and pyrimidine synthesis, namely thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT). By disrupting these pathways, Pemetrexed Disodium effectively blocks the production of DNA and RNA precursors. This inhibition halts the proliferation of rapidly dividing cells, a characteristic of both cancer cells and, to a lesser extent, normal cells.
The drug is transported into cells via reduced folate carrier 1 (RFC-1) and folylpolyglutamate synthetase (FPGS) enzymes, which convert Pemetrexed into its polyglutamated forms. These polyglutamated metabolites are retained within cells for longer periods and exhibit enhanced inhibitory activity against folate-dependent enzymes, contributing to the drug's potent cytotoxic effect.
Therapeutic Applications in Oncology
Pemetrexed Disodium has demonstrated significant efficacy in the treatment of specific malignancies:
Clinical Considerations and Patient Management
To mitigate potential toxicities associated with Pemetrexed Disodium therapy, patients are typically prescribed folic acid and vitamin B12 supplementation. These supplements help reduce the incidence and severity of certain side effects, such as hematologic toxicity and mucositis. Additionally, corticosteroid premedication is often administered to minimize the risk of skin rash, a common adverse effect.
Pemetrexed Disodium as a Pharmaceutical Intermediate
From a manufacturing perspective, Pemetrexed Disodium serves as a critical pharmaceutical intermediate. Companies aiming to buy Pemetrexed Disodium for API synthesis must ensure they are sourcing from a Pemetrexed Disodium manufacturer or supplier that guarantees high purity and consistent quality. The complex synthesis and stringent quality requirements underscore the importance of reliable sourcing partners in the pharmaceutical industry.
The pharmacological profile of Pemetrexed Disodium highlights its importance in modern cancer treatment. For pharmaceutical professionals, a thorough understanding of its mechanism, applications, and the associated clinical management is essential for its effective utilization and development.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.